Study on A beta 34 biology and detection in transgenic mice brains
The beta -amyloid precursor protein undergoes cleavages by beta - and gamma -secretasses yielding amyloid- beta peptides (A beta ) that accumulate in Alzheimer's disease. Subsequently, A beta peptides are targets of additional truncations or endoproteolytic cleavages explaining the diversity of...
Gespeichert in:
Veröffentlicht in: | Neurobiology of aging 2014-07, Vol.35 (7), p.1570-1581 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The beta -amyloid precursor protein undergoes cleavages by beta - and gamma -secretasses yielding amyloid- beta peptides (A beta ) that accumulate in Alzheimer's disease. Subsequently, A beta peptides are targets of additional truncations or endoproteolytic cleavages explaining the diversity of A beta -related fragments recovered in cell media or pathologic human fluids. Here, we focused on A beta 1-34 (A beta 34) that has been detected both in vitro and in vivo and that derives from the hydrolysis of A beta by beta -secretase. We have obtained and fully characterized by immunologic and biochemical approaches, a polyclonal antibody that specifically recognizes the C-terminus of A beta x-34. We present immunohistochemical evidence for the presence of A beta x-34 in the brain of 3xTg mice and Alzheimer's disease-affected human brains. Finally, we demonstrate a neprilysin-mediated degradation process of A beta 34 and the ability of synthetic A beta 34 to protect HEK cells overexpressing either wild type or Swedish-mutated beta -amyloid precursor protein from apoptosis. |
---|---|
ISSN: | 0197-4580 |
DOI: | 10.1016/j.neurobiolaging.2014.01.011 |